Bluejay Diagnostics Q4 EPS $(1.78) Misses $(0.68) Estimate
Bluejay Diagnostics Q4 EPS $(1.78) Misses $(0.68) Estimate
Bluejay Diagnostics第四季度每股收益美元(1.78美元)未达到预期(0.68美元)
Bluejay Diagnostics (NASDAQ:BJDX) reported quarterly losses of $(1.78) per share which missed the analyst consensus estimate of $(0.68) by 161.76 percent. This is a 25.83 percent increase over losses of $(2.40) per share from the same period last year.
Bluejay Diagnostics(纳斯达克股票代码:BJDX)公布的季度亏损为每股1.78美元,比分析师普遍预期的0.68美元(0.68美元)低161.76%。这比去年同期每股亏损2.40美元(2.40美元)增长了25.83%。